Urinary transferrin and proinflammatory markers predict the earliest diabetic nephropathy onset.

Ahmed, Samia A; Aziz, Wessam M; Shaker, Sylvia E; Fayed, Dalia B; Shawky, Heba

Ahmed, Samia A; Aziz, Wessam M; Shaker, Sylvia E; Fayed, Dalia B; Shawky, Heba.

Afiliação

Ahmed SA; Therapeutic Chemistry Department, Pharmaceutical and Drug Industries Research Institute, National Research Centre, Dokki, Egypt.
Aziz WM; Therapeutic Chemistry Department, Pharmaceutical and Drug Industries Research Institute, National Research Centre, Dokki, Egypt.
Shaker SE; Therapeutic Chemistry Department, Pharmaceutical and Drug Industries Research Institute, National Research Centre, Dokki, Egypt.
Fayed DB; Therapeutic Chemistry Department, Pharmaceutical and Drug Industries Research Institute, National Research Centre, Dokki, Egypt.
Shawky H; Therapeutic Chemistry Department, Pharmaceutical and Drug Industries Research Institute, National Research Centre, Dokki, Egypt.

Biomarkers ; 27(2): 178-187, 2022 Mar.

Article em En | MEDLINE | ID: mdl-34957874

Assuntos

Diabetes Mellitus; Nefropatias Diabéticas; Animais; Biomarcadores/urina; Nefropatias Diabéticas/diagnóstico; Humanos; Masculino; Curva ROC; Ratos; Ratos Wistar; Transferrina

Palavras-chave

Diabetic nephropathy; biomarker; end-stage kidney disease; microalbuminuria; proinflammatory cytokines; transferrin

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Diabetes Mellitus / Nefropatias Diabéticas Tipo de estudo: Diagnostic_studies / Prognostic_studies / Risk_factors_studies Limite: Animals / Humans / Male Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google